U.S. Logistics Stock News

As the U.S. stock market kicks off February with significant gains, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing a record high, investors are keenly observing opportunities amid this bullish sentiment. In such an environment, identifying stocks that may be trading below their fair value can present potential investment opportunities, particularly when considering companies like Autodesk and others that might offer strong fundamentals at attractive...

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...

Southside Bancshares (SBSI) shares are trading around $33.30 after the bank reported full year 2025 results, which showed higher net interest income but lower net income and earnings per share compared with 2024. See our latest analysis for Southside Bancshares. The stock’s recent performance reflects mixed sentiment, with a 15.54% 90 day share price return and 9.36% year to date share price return. The 3 year total shareholder return is slightly negative and the 5 year total shareholder...

CNA Financial (CNA) has wrapped up FY 2025 with fourth quarter total revenue of US$3.8 billion, basic EPS of US$1.11 and net income of US$302 million. Its trailing twelve month figures show revenue of US$15.0 billion, EPS of US$4.71 and net income of US$1.28 billion. Over the past year, the company has seen revenue move from US$14.3 billion to US$15.0 billion and trailing EPS shift from US$3.53 to US$4.71. This sets the backdrop for how you might read this latest print. With net profit margin...

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...

Setting the scene with Danaos's latest numbers Danaos (DAC) has just wrapped up FY 2025 with fourth quarter revenue of US$266.3 million and basic EPS of US$6.43, capping a year in which trailing twelve month revenue sat at about US$1.0 billion and EPS at US$26.83. The company has seen revenue move from US$258.2 million and EPS of US$4.72 in Q4 2024 to the latest Q4 2025 figures. Over the same period, trailing twelve month revenue slipped from US$1.01 billion and EPS from US$26.15 a year...

Hawkins' subsidiary WaterSurplus will supply 1,050 NanoStack coated membranes to the Orange County Water District’s Groundwater Replenishment System. The decision follows a successful pilot and represents deployment into what is described as the world’s leading potable water reuse system. The project highlights Hawkins' role in advanced water treatment solutions for large scale reuse facilities. For investors watching NasdaqGS:HWKN, this contract sits alongside a share price of $143.51 and...

The Gorman-Rupp Company ( NYSE:GRC ) shares have continued their recent momentum with a 31% gain in the last month...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

How Bank of N.T. Butterfield & Son (NYSE:NTB)'s FY 2025 Numbers Set the Stage Bank of N.T. Butterfield & Son (NYSE:NTB) has reported a clean set of FY 2025 numbers, with fourth quarter revenue of US$159.1 million and basic EPS of US$1.58 anchoring the latest release. Over the past year, the bank has recorded trailing twelve month revenue of US$606.7 million and basic EPS of US$5.71. This gives investors a fuller picture of how the quarterly performance fits within the broader trend. With a...

Ichor Holdings (ICHR) just wrapped up FY 2025 with Q4 revenue of US$223.6 million and a basic EPS loss of US$0.46, while trailing twelve month figures show revenue of US$947.7 million and a basic EPS loss of US$1.54. Over recent quarters, the company has seen quarterly revenue move between US$211.1 million and US$244.5 million, with basic EPS losses ranging from US$0.08 to US$0.67. This pattern keeps the focus squarely on how efficiently each dollar of sales is translating into earnings. With...

Ciena Corporation ( NYSE:CIEN ) shares have continued their recent momentum with a 30% gain in the last month alone...

Verizon Communications Inc. ( NYSE:VZ ) will increase its dividend from last year's comparable payment on the 1st of...

The loanDepot, Inc. ( NYSE:LDI ) share price has fared very poorly over the last month, falling by a substantial 27...

Molina Healthcare, Inc. ( NYSE:MOH ) shares have had a horrible month, losing 31% after a relatively good period...

iRhythm Technologies, Inc. has voluntarily deregistered its Common Stock. The company has completed a holding company reorganization. iRhythm Holdings, Inc. now serves as the new public entity for shareholders. The changes affect the stock associated with NasdaqGS:IRTC and the prior operating company. iRhythm focuses on cardiac monitoring solutions, so any change in its corporate structure tends to attract attention from investors who follow medical technology names. The move to a holding...

Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.52 on 6th of...

CVS Health (CVS) closed out FY 2025 with fourth quarter revenue of US$105.1 billion, Basic EPS of US$2.32 and net income of US$2,943 million, following a year in which trailing twelve month revenue reached US$399.8 billion, Basic EPS stood at US$1.40 and net income was US$1,768 million. The company has seen quarterly revenue move from US$96.9 billion in Q4 2024 to US$105.1 billion in Q4 2025, while Basic EPS shifted from US$1.31 to US$2.32 over the same period, against a backdrop of a...

Q1 2026 results and what they signal for Lee Enterprises Lee Enterprises (LEE) has opened fiscal 2026 with Q1 revenue of US$130.1 million and a basic EPS loss of US$0.92, alongside a trailing 12 month EPS loss of US$4.34 that keeps the story firmly in loss making territory. Over recent quarters, the company has seen revenue move from US$144.6 million in Q1 2025 to US$130.1 million in Q1 2026, while quarterly basic EPS has ranged from a loss of US$2.80 in Q1 2025 to a loss of US$0.92 in the...

Amkor Technology (AMKR) has just posted its FY 2025 numbers, with Q4 revenue of about US$1.9b, basic EPS of US$0.69 and net income excluding extra items of US$171.8m. Trailing twelve month EPS sits at US$1.51 on revenue of roughly US$6.7b and net income of US$373.9m. Over recent quarters the company has seen revenue move from US$1.32b and EPS of US$0.09 in Q1 2025 to US$1.99b and EPS of US$0.51 in Q3 2025, before landing at Q4’s US$1.9b and US$0.69. This sets up a picture where margins are...

Unitil (UTL) has wrapped up FY 2025 with fourth quarter revenue of US$161.5 million, basic EPS of US$1.05 and net income of US$19.2 million. On a trailing twelve month basis, revenue sits at US$536 million with basic EPS of US$2.97 and net income of US$50.2 million. The company has seen revenue move from US$494.8 million to US$536 million over recent trailing periods, with basic EPS shifting from US$2.93 to US$2.97, presenting a picture where steady profit generation aligns with largely...